avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nfia
|
ENSMUSG00000028565.19 | Nfia |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nfia | mm39_v1_chr4_+_97665992_97666071 | 0.50 | 1.9e-03 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_97066937 | 23.91 |
ENSMUST00000043077.8
|
Thrsp
|
thyroid hormone responsive |
chr7_+_140343652 | 23.83 |
ENSMUST00000026552.9
ENSMUST00000209253.2 ENSMUST00000210235.2 |
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
chr3_-_81883509 | 16.61 |
ENSMUST00000029645.14
ENSMUST00000193879.2 |
Tdo2
|
tryptophan 2,3-dioxygenase |
chr8_-_93857899 | 16.53 |
ENSMUST00000034189.17
|
Ces1c
|
carboxylesterase 1C |
chr11_-_5865124 | 14.47 |
ENSMUST00000109823.9
ENSMUST00000109822.8 |
Gck
|
glucokinase |
chr12_+_104304631 | 14.11 |
ENSMUST00000043058.5
ENSMUST00000101078.12 |
Serpina3k
Serpina3m
|
serine (or cysteine) peptidase inhibitor, clade A, member 3K serine (or cysteine) peptidase inhibitor, clade A, member 3M |
chr4_-_61972348 | 13.31 |
ENSMUST00000074018.4
|
Mup20
|
major urinary protein 20 |
chr1_+_87998487 | 13.21 |
ENSMUST00000073772.5
|
Ugt1a9
|
UDP glucuronosyltransferase 1 family, polypeptide A9 |
chr19_-_44396092 | 13.20 |
ENSMUST00000041331.4
|
Scd1
|
stearoyl-Coenzyme A desaturase 1 |
chr4_-_61437704 | 13.13 |
ENSMUST00000095051.6
ENSMUST00000107483.8 |
Mup16
|
major urinary protein 16 |
chr4_-_60777462 | 12.73 |
ENSMUST00000211875.2
|
Mup22
|
major urinary protein 22 |
chr4_-_61700450 | 12.69 |
ENSMUST00000107477.2
ENSMUST00000080606.9 |
Mup19
|
major urinary protein 19 |
chr4_-_60139857 | 11.92 |
ENSMUST00000107490.5
ENSMUST00000074700.9 |
Mup2
|
major urinary protein 2 |
chr3_+_94284812 | 11.74 |
ENSMUST00000200009.2
|
Rorc
|
RAR-related orphan receptor gamma |
chr3_+_14928561 | 11.73 |
ENSMUST00000029076.6
|
Car3
|
carbonic anhydrase 3 |
chr10_-_128796834 | 11.50 |
ENSMUST00000026398.5
|
Mettl7b
|
methyltransferase like 7B |
chr17_-_33136021 | 11.41 |
ENSMUST00000054174.9
|
Cyp4f14
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
chr6_-_5193816 | 11.39 |
ENSMUST00000002663.12
|
Pon1
|
paraoxonase 1 |
chr6_-_5193757 | 11.28 |
ENSMUST00000177159.9
ENSMUST00000176945.2 |
Pon1
|
paraoxonase 1 |
chr4_-_61259801 | 11.18 |
ENSMUST00000125461.8
|
Mup14
|
major urinary protein 14 |
chr3_+_94284739 | 11.13 |
ENSMUST00000197040.5
|
Rorc
|
RAR-related orphan receptor gamma |
chr5_+_146016064 | 10.81 |
ENSMUST00000035571.10
|
Cyp3a59
|
cytochrome P450, family 3, subfamily a, polypeptide 59 |
chr17_+_32904629 | 10.52 |
ENSMUST00000008801.7
|
Cyp4f15
|
cytochrome P450, family 4, subfamily f, polypeptide 15 |
chr9_-_57590926 | 10.41 |
ENSMUST00000034860.5
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2 |
chr19_-_44396269 | 10.33 |
ENSMUST00000235741.2
|
Scd1
|
stearoyl-Coenzyme A desaturase 1 |
chr1_-_130589349 | 10.30 |
ENSMUST00000027657.14
|
C4bp
|
complement component 4 binding protein |
chr1_-_130589321 | 10.25 |
ENSMUST00000137276.3
|
C4bp
|
complement component 4 binding protein |
chr14_+_66208059 | 10.21 |
ENSMUST00000127387.8
|
Clu
|
clusterin |
chr7_-_48497771 | 9.78 |
ENSMUST00000032658.14
|
Csrp3
|
cysteine and glycine-rich protein 3 |
chr3_+_137983250 | 9.58 |
ENSMUST00000004232.10
|
Adh1
|
alcohol dehydrogenase 1 (class I) |
chr17_+_32904601 | 9.57 |
ENSMUST00000168171.8
|
Cyp4f15
|
cytochrome P450, family 4, subfamily f, polypeptide 15 |
chr2_+_121978156 | 9.33 |
ENSMUST00000102476.5
|
B2m
|
beta-2 microglobulin |
chr14_+_66207163 | 9.24 |
ENSMUST00000153460.8
|
Clu
|
clusterin |
chr11_+_101258368 | 9.03 |
ENSMUST00000019469.3
|
G6pc
|
glucose-6-phosphatase, catalytic |
chr7_-_105249308 | 9.00 |
ENSMUST00000210531.2
ENSMUST00000033185.10 |
Hpx
|
hemopexin |
chr16_-_10360893 | 8.87 |
ENSMUST00000184863.8
ENSMUST00000038281.6 |
Dexi
|
dexamethasone-induced transcript |
chr6_-_141801897 | 8.75 |
ENSMUST00000165990.8
|
Slco1a4
|
solute carrier organic anion transporter family, member 1a4 |
chr2_+_172994841 | 8.63 |
ENSMUST00000029017.6
|
Pck1
|
phosphoenolpyruvate carboxykinase 1, cytosolic |
chr5_-_137919873 | 8.55 |
ENSMUST00000031741.8
|
Cyp3a13
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
chr7_+_51528788 | 8.48 |
ENSMUST00000107591.9
|
Gas2
|
growth arrest specific 2 |
chr15_-_3612628 | 8.29 |
ENSMUST00000110698.9
|
Ghr
|
growth hormone receptor |
chr1_+_72863641 | 8.02 |
ENSMUST00000047328.11
|
Igfbp2
|
insulin-like growth factor binding protein 2 |
chr5_-_145946408 | 7.85 |
ENSMUST00000138870.2
ENSMUST00000068317.13 |
Cyp3a25
|
cytochrome P450, family 3, subfamily a, polypeptide 25 |
chr1_+_167445815 | 7.68 |
ENSMUST00000111380.2
|
Rxrg
|
retinoid X receptor gamma |
chr19_-_46661321 | 7.64 |
ENSMUST00000026012.8
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1 |
chr11_-_4068779 | 7.55 |
ENSMUST00000003681.8
|
Sec14l2
|
SEC14-like lipid binding 2 |
chr3_-_129126362 | 7.42 |
ENSMUST00000029658.14
|
Enpep
|
glutamyl aminopeptidase |
chr7_-_25358406 | 7.32 |
ENSMUST00000071329.8
|
Bckdha
|
branched chain ketoacid dehydrogenase E1, alpha polypeptide |
chr8_+_105858432 | 7.26 |
ENSMUST00000161289.2
|
Ces4a
|
carboxylesterase 4A |
chr19_-_46661501 | 7.19 |
ENSMUST00000236174.2
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1 |
chr18_+_12776358 | 7.03 |
ENSMUST00000234966.2
ENSMUST00000025294.9 |
Ttc39c
|
tetratricopeptide repeat domain 39C |
chr3_-_131096792 | 7.02 |
ENSMUST00000200236.2
ENSMUST00000106337.7 |
Cyp2u1
|
cytochrome P450, family 2, subfamily u, polypeptide 1 |
chr5_-_87288177 | 6.98 |
ENSMUST00000067790.7
|
Ugt2b5
|
UDP glucuronosyltransferase 2 family, polypeptide B5 |
chr1_-_162726234 | 6.97 |
ENSMUST00000111510.8
ENSMUST00000045902.13 |
Fmo2
|
flavin containing monooxygenase 2 |
chr17_-_34218301 | 6.52 |
ENSMUST00000235463.2
|
H2-K1
|
histocompatibility 2, K1, K region |
chr6_-_141801918 | 6.48 |
ENSMUST00000163678.2
|
Slco1a4
|
solute carrier organic anion transporter family, member 1a4 |
chr15_-_3612703 | 6.44 |
ENSMUST00000069451.11
|
Ghr
|
growth hormone receptor |
chr15_+_10314173 | 6.20 |
ENSMUST00000127467.3
|
Prlr
|
prolactin receptor |
chr3_+_97536120 | 6.20 |
ENSMUST00000107050.8
ENSMUST00000029729.15 ENSMUST00000107049.2 |
Fmo5
|
flavin containing monooxygenase 5 |
chr6_+_138117295 | 6.12 |
ENSMUST00000008684.11
|
Mgst1
|
microsomal glutathione S-transferase 1 |
chr15_+_88973276 | 6.00 |
ENSMUST00000082439.6
|
Selenoo
|
selenoprotein O |
chr18_+_20798337 | 5.93 |
ENSMUST00000075312.5
|
Ttr
|
transthyretin |
chr6_+_138117519 | 5.73 |
ENSMUST00000120939.8
ENSMUST00000204628.3 ENSMUST00000140932.2 ENSMUST00000120302.8 |
Mgst1
|
microsomal glutathione S-transferase 1 |
chr11_+_115353290 | 5.72 |
ENSMUST00000106532.4
ENSMUST00000092445.12 ENSMUST00000153466.2 |
Slc16a5
|
solute carrier family 16 (monocarboxylic acid transporters), member 5 |
chr10_+_75729237 | 5.71 |
ENSMUST00000009236.6
ENSMUST00000217811.2 |
Derl3
|
Der1-like domain family, member 3 |
chr17_-_57529827 | 5.58 |
ENSMUST00000177425.2
|
C3
|
complement component 3 |
chr17_-_34219225 | 5.58 |
ENSMUST00000238098.2
ENSMUST00000087189.7 ENSMUST00000173075.3 ENSMUST00000172912.8 ENSMUST00000236740.2 ENSMUST00000025181.18 |
H2-K1
|
histocompatibility 2, K1, K region |
chr13_-_69759541 | 5.55 |
ENSMUST00000091514.6
|
Srd5a1
|
steroid 5 alpha-reductase 1 |
chr14_-_64654397 | 5.47 |
ENSMUST00000210428.2
|
Msra
|
methionine sulfoxide reductase A |
chr14_-_64654592 | 5.33 |
ENSMUST00000210363.2
|
Msra
|
methionine sulfoxide reductase A |
chr18_+_32055339 | 5.32 |
ENSMUST00000233994.2
|
Lims2
|
LIM and senescent cell antigen like domains 2 |
chr10_-_24588030 | 5.28 |
ENSMUST00000105520.8
|
Enpp1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
chr13_+_25127127 | 5.27 |
ENSMUST00000021773.13
|
Gpld1
|
glycosylphosphatidylinositol specific phospholipase D1 |
chr5_-_31453206 | 5.26 |
ENSMUST00000041266.11
ENSMUST00000172435.8 ENSMUST00000201417.2 |
Fndc4
|
fibronectin type III domain containing 4 |
chr7_-_99344779 | 5.21 |
ENSMUST00000137914.2
ENSMUST00000207090.2 ENSMUST00000208225.2 |
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr1_+_58152295 | 5.20 |
ENSMUST00000040999.14
ENSMUST00000162011.3 |
Aox3
|
aldehyde oxidase 3 |
chr5_-_77262968 | 5.12 |
ENSMUST00000081964.7
|
Hopx
|
HOP homeobox |
chr6_-_124519240 | 5.09 |
ENSMUST00000159463.8
ENSMUST00000162844.2 ENSMUST00000160505.8 ENSMUST00000162443.8 |
C1s1
|
complement component 1, s subcomponent 1 |
chr1_-_155688635 | 5.03 |
ENSMUST00000035325.15
|
Qsox1
|
quiescin Q6 sulfhydryl oxidase 1 |
chr10_-_24587884 | 5.00 |
ENSMUST00000135846.2
|
Enpp1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
chr3_+_130411097 | 5.00 |
ENSMUST00000166187.8
ENSMUST00000072271.13 |
Etnppl
|
ethanolamine phosphate phospholyase |
chr2_+_164404499 | 5.00 |
ENSMUST00000017867.10
ENSMUST00000109344.9 ENSMUST00000109345.9 |
Wfdc2
|
WAP four-disulfide core domain 2 |
chr11_+_98938137 | 4.96 |
ENSMUST00000140772.2
|
Igfbp4
|
insulin-like growth factor binding protein 4 |
chr17_-_35077089 | 4.95 |
ENSMUST00000153400.8
|
Cfb
|
complement factor B |
chr6_+_113460258 | 4.95 |
ENSMUST00000032422.6
|
Creld1
|
cysteine-rich with EGF-like domains 1 |
chr15_-_34495329 | 4.91 |
ENSMUST00000022946.6
|
Rida
|
reactive intermediate imine deaminase A homolog |
chr11_-_94492688 | 4.91 |
ENSMUST00000103164.4
|
Acsf2
|
acyl-CoA synthetase family member 2 |
chr19_+_44191704 | 4.88 |
ENSMUST00000026220.7
|
Scd3
|
stearoyl-coenzyme A desaturase 3 |
chr8_-_106670014 | 4.73 |
ENSMUST00000038896.8
|
Lcat
|
lecithin cholesterol acyltransferase |
chr4_-_62069046 | 4.69 |
ENSMUST00000077719.4
|
Mup21
|
major urinary protein 21 |
chr8_-_95405234 | 4.64 |
ENSMUST00000213043.2
|
Pllp
|
plasma membrane proteolipid |
chr1_+_88022776 | 4.60 |
ENSMUST00000150634.8
ENSMUST00000058237.14 |
Ugt1a7c
|
UDP glucuronosyltransferase 1 family, polypeptide A7C |
chr7_-_45138188 | 4.58 |
ENSMUST00000011526.7
|
Dhdh
|
dihydrodiol dehydrogenase (dimeric) |
chr1_+_127657142 | 4.56 |
ENSMUST00000038006.8
|
Acmsd
|
amino carboxymuconate semialdehyde decarboxylase |
chr7_+_119217004 | 4.54 |
ENSMUST00000047929.13
ENSMUST00000135683.3 |
Acsm1
|
acyl-CoA synthetase medium-chain family member 1 |
chrX_-_47297436 | 4.47 |
ENSMUST00000037960.11
|
Zdhhc9
|
zinc finger, DHHC domain containing 9 |
chr14_-_66361931 | 4.47 |
ENSMUST00000070515.2
|
Ephx2
|
epoxide hydrolase 2, cytoplasmic |
chr16_+_22676589 | 4.44 |
ENSMUST00000004574.14
ENSMUST00000178320.2 ENSMUST00000166487.10 |
Dnajb11
|
DnaJ heat shock protein family (Hsp40) member B11 |
chr19_-_38113056 | 4.33 |
ENSMUST00000236283.2
|
Rbp4
|
retinol binding protein 4, plasma |
chr3_+_94280101 | 4.29 |
ENSMUST00000029795.10
|
Rorc
|
RAR-related orphan receptor gamma |
chr16_-_21606546 | 4.28 |
ENSMUST00000023559.7
|
Ehhadh
|
enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase |
chr7_+_26895206 | 4.26 |
ENSMUST00000179391.8
ENSMUST00000108379.8 |
BC024978
|
cDNA sequence BC024978 |
chr10_-_127206300 | 4.21 |
ENSMUST00000026472.10
|
Inhbc
|
inhibin beta-C |
chr1_+_87983189 | 4.13 |
ENSMUST00000173325.2
|
Ugt1a10
|
UDP glycosyltransferase 1 family, polypeptide A10 |
chrX_+_37405054 | 4.10 |
ENSMUST00000016471.9
ENSMUST00000115134.2 |
Atp1b4
|
ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
chr7_-_4633472 | 4.09 |
ENSMUST00000055085.8
|
Tmem86b
|
transmembrane protein 86B |
chr5_-_65593217 | 4.03 |
ENSMUST00000031103.14
|
Ugdh
|
UDP-glucose dehydrogenase |
chr11_-_70405429 | 3.98 |
ENSMUST00000021179.4
|
Vmo1
|
vitelline membrane outer layer 1 homolog (chicken) |
chr7_+_51528715 | 3.97 |
ENSMUST00000051912.13
|
Gas2
|
growth arrest specific 2 |
chr4_+_140970161 | 3.96 |
ENSMUST00000138096.8
ENSMUST00000006618.9 ENSMUST00000125392.8 |
Arhgef19
|
Rho guanine nucleotide exchange factor (GEF) 19 |
chr11_-_77784922 | 3.94 |
ENSMUST00000017597.5
|
Pipox
|
pipecolic acid oxidase |
chr1_-_162687254 | 3.87 |
ENSMUST00000131058.8
|
Fmo1
|
flavin containing monooxygenase 1 |
chr11_+_78389913 | 3.83 |
ENSMUST00000017488.5
|
Vtn
|
vitronectin |
chr11_-_120508713 | 3.83 |
ENSMUST00000106188.4
ENSMUST00000026129.16 |
Pcyt2
|
phosphate cytidylyltransferase 2, ethanolamine |
chr15_-_39720855 | 3.79 |
ENSMUST00000022915.11
ENSMUST00000110306.9 |
Dpys
|
dihydropyrimidinase |
chr17_+_35482063 | 3.78 |
ENSMUST00000172503.3
|
H2-D1
|
histocompatibility 2, D region locus 1 |
chr7_+_112806672 | 3.75 |
ENSMUST00000047321.9
ENSMUST00000210074.2 ENSMUST00000210238.2 |
Arntl
|
aryl hydrocarbon receptor nuclear translocator-like |
chr3_+_130411294 | 3.71 |
ENSMUST00000163620.8
|
Etnppl
|
ethanolamine phosphate phospholyase |
chr16_+_51851917 | 3.71 |
ENSMUST00000227062.2
|
Cblb
|
Casitas B-lineage lymphoma b |
chrX_-_74918709 | 3.70 |
ENSMUST00000114059.10
|
Pls3
|
plastin 3 (T-isoform) |
chr4_-_49549489 | 3.66 |
ENSMUST00000029987.10
|
Aldob
|
aldolase B, fructose-bisphosphate |
chr7_-_99344832 | 3.66 |
ENSMUST00000145381.8
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr10_-_89342493 | 3.63 |
ENSMUST00000058126.15
ENSMUST00000105296.9 |
Nr1h4
|
nuclear receptor subfamily 1, group H, member 4 |
chr4_-_46536088 | 3.62 |
ENSMUST00000102924.3
ENSMUST00000046897.13 |
Trim14
|
tripartite motif-containing 14 |
chr6_+_90310252 | 3.62 |
ENSMUST00000046128.12
ENSMUST00000164761.6 |
Uroc1
|
urocanase domain containing 1 |
chr11_-_61269131 | 3.62 |
ENSMUST00000148671.2
|
Slc47a1
|
solute carrier family 47, member 1 |
chr17_-_74257164 | 3.53 |
ENSMUST00000024866.6
|
Xdh
|
xanthine dehydrogenase |
chr10_-_115198093 | 3.52 |
ENSMUST00000219890.2
ENSMUST00000218731.2 ENSMUST00000217887.2 ENSMUST00000092170.7 |
Tmem19
|
transmembrane protein 19 |
chr4_-_129121676 | 3.51 |
ENSMUST00000106051.8
|
C77080
|
expressed sequence C77080 |
chr9_+_119170360 | 3.51 |
ENSMUST00000039784.12
|
Acaa1a
|
acetyl-Coenzyme A acyltransferase 1A |
chr1_-_162687369 | 3.47 |
ENSMUST00000193078.6
|
Fmo1
|
flavin containing monooxygenase 1 |
chr7_-_4633186 | 3.47 |
ENSMUST00000205360.2
ENSMUST00000206610.2 |
Tmem86b
|
transmembrane protein 86B |
chr11_+_75400889 | 3.47 |
ENSMUST00000042972.7
|
Rilp
|
Rab interacting lysosomal protein |
chr5_+_87148697 | 3.46 |
ENSMUST00000031186.9
|
Ugt2b35
|
UDP glucuronosyltransferase 2 family, polypeptide B35 |
chr11_+_120382666 | 3.46 |
ENSMUST00000026899.4
|
Slc25a10
|
solute carrier family 25 (mitochondrial carrier, dicarboxylate transporter), member 10 |
chr8_-_3767547 | 3.43 |
ENSMUST00000058040.7
|
Clec4g
|
C-type lectin domain family 4, member g |
chrX_-_72759748 | 3.43 |
ENSMUST00000002091.6
|
Bcap31
|
B cell receptor associated protein 31 |
chr19_-_42190589 | 3.43 |
ENSMUST00000018966.8
|
Sfrp5
|
secreted frizzled-related sequence protein 5 |
chr9_+_107454114 | 3.42 |
ENSMUST00000112387.9
ENSMUST00000123005.8 ENSMUST00000010195.14 ENSMUST00000144392.2 |
Hyal1
|
hyaluronoglucosaminidase 1 |
chr18_-_62044871 | 3.40 |
ENSMUST00000166783.3
ENSMUST00000049378.15 |
Ablim3
|
actin binding LIM protein family, member 3 |
chrX_-_47297746 | 3.38 |
ENSMUST00000088935.4
|
Zdhhc9
|
zinc finger, DHHC domain containing 9 |
chr2_-_32314017 | 3.38 |
ENSMUST00000113307.9
|
Slc25a25
|
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
chr7_+_143027473 | 3.37 |
ENSMUST00000052348.12
|
Slc22a18
|
solute carrier family 22 (organic cation transporter), member 18 |
chr10_+_75242745 | 3.36 |
ENSMUST00000039925.8
|
Upb1
|
ureidopropionase, beta |
chr8_+_129085719 | 3.33 |
ENSMUST00000026917.10
|
Nrp1
|
neuropilin 1 |
chr19_+_42024439 | 3.30 |
ENSMUST00000238137.2
ENSMUST00000026172.3 |
Ankrd2
|
ankyrin repeat domain 2 (stretch responsive muscle) |
chr9_+_74860335 | 3.30 |
ENSMUST00000170846.8
|
Fam214a
|
family with sequence similarity 214, member A |
chr1_-_155688551 | 3.27 |
ENSMUST00000194632.2
ENSMUST00000111764.8 |
Qsox1
|
quiescin Q6 sulfhydryl oxidase 1 |
chr1_+_93163553 | 3.26 |
ENSMUST00000062202.14
|
Sned1
|
sushi, nidogen and EGF-like domains 1 |
chr6_+_113448388 | 3.25 |
ENSMUST00000058300.14
|
Il17rc
|
interleukin 17 receptor C |
chr13_-_56696222 | 3.23 |
ENSMUST00000225183.2
|
Lect2
|
leukocyte cell-derived chemotaxin 2 |
chr12_-_44257109 | 3.18 |
ENSMUST00000015049.5
|
Dnajb9
|
DnaJ heat shock protein family (Hsp40) member B9 |
chr4_+_140688514 | 3.18 |
ENSMUST00000010007.9
|
Sdhb
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip) |
chr11_-_106469938 | 3.18 |
ENSMUST00000103070.3
|
Tex2
|
testis expressed gene 2 |
chr15_-_98575332 | 3.17 |
ENSMUST00000120997.2
ENSMUST00000109149.9 ENSMUST00000003451.11 |
Rnd1
|
Rho family GTPase 1 |
chr11_+_28803188 | 3.12 |
ENSMUST00000020759.12
|
Efemp1
|
epidermal growth factor-containing fibulin-like extracellular matrix protein 1 |
chr7_-_126496534 | 3.09 |
ENSMUST00000120007.8
|
Tmem219
|
transmembrane protein 219 |
chr7_+_100970910 | 3.09 |
ENSMUST00000174291.8
ENSMUST00000167888.9 ENSMUST00000172662.2 |
Stard10
|
START domain containing 10 |
chr9_-_103099262 | 3.07 |
ENSMUST00000170904.2
|
Trf
|
transferrin |
chr9_+_37466989 | 3.07 |
ENSMUST00000213126.2
|
Siae
|
sialic acid acetylesterase |
chr6_-_83098255 | 3.06 |
ENSMUST00000205023.2
ENSMUST00000146328.4 ENSMUST00000151393.7 ENSMUST00000032111.11 ENSMUST00000113936.10 |
Wbp1
|
WW domain binding protein 1 |
chr7_+_28937859 | 3.04 |
ENSMUST00000108237.2
|
Yif1b
|
Yip1 interacting factor homolog B (S. cerevisiae) |
chr5_+_90608751 | 3.04 |
ENSMUST00000031314.10
|
Alb
|
albumin |
chr11_-_105835238 | 3.04 |
ENSMUST00000019734.11
ENSMUST00000184269.3 ENSMUST00000150563.3 |
Cyb561
|
cytochrome b-561 |
chr7_+_114344920 | 3.02 |
ENSMUST00000136645.8
ENSMUST00000169913.8 |
Insc
|
INSC spindle orientation adaptor protein |
chr15_-_76501525 | 2.99 |
ENSMUST00000230977.2
|
Slc39a4
|
solute carrier family 39 (zinc transporter), member 4 |
chr9_+_106324952 | 2.97 |
ENSMUST00000215475.2
ENSMUST00000187106.7 ENSMUST00000190167.7 |
Abhd14b
|
abhydrolase domain containing 14b |
chr2_+_119181703 | 2.95 |
ENSMUST00000028780.4
|
Chac1
|
ChaC, cation transport regulator 1 |
chr8_+_46111703 | 2.94 |
ENSMUST00000134675.8
ENSMUST00000139869.8 ENSMUST00000126067.8 |
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr14_-_118289557 | 2.94 |
ENSMUST00000022725.4
|
Dct
|
dopachrome tautomerase |
chr6_-_136852792 | 2.94 |
ENSMUST00000032342.3
|
Mgp
|
matrix Gla protein |
chr6_+_90442269 | 2.93 |
ENSMUST00000113530.4
|
Klf15
|
Kruppel-like factor 15 |
chr4_+_105014536 | 2.91 |
ENSMUST00000064139.8
|
Plpp3
|
phospholipid phosphatase 3 |
chr15_+_32920869 | 2.89 |
ENSMUST00000022871.7
|
Sdc2
|
syndecan 2 |
chr13_+_41040657 | 2.87 |
ENSMUST00000069958.15
|
Gcnt2
|
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme |
chr9_-_106562852 | 2.86 |
ENSMUST00000169068.8
|
Tex264
|
testis expressed gene 264 |
chr1_+_93062962 | 2.84 |
ENSMUST00000027491.7
|
Agxt
|
alanine-glyoxylate aminotransferase |
chr10_-_115197775 | 2.83 |
ENSMUST00000217848.2
|
Tmem19
|
transmembrane protein 19 |
chr19_-_6117815 | 2.79 |
ENSMUST00000162575.8
ENSMUST00000159084.8 ENSMUST00000161718.8 ENSMUST00000162810.8 ENSMUST00000025713.12 ENSMUST00000113543.9 ENSMUST00000160417.8 ENSMUST00000161528.2 |
Tm7sf2
|
transmembrane 7 superfamily member 2 |
chr11_+_98932586 | 2.78 |
ENSMUST00000177092.8
|
Igfbp4
|
insulin-like growth factor binding protein 4 |
chr6_-_115228800 | 2.76 |
ENSMUST00000205131.2
|
Timp4
|
tissue inhibitor of metalloproteinase 4 |
chr3_+_122305819 | 2.73 |
ENSMUST00000199344.2
|
Bcar3
|
breast cancer anti-estrogen resistance 3 |
chr6_+_108805594 | 2.73 |
ENSMUST00000089162.5
|
Edem1
|
ER degradation enhancer, mannosidase alpha-like 1 |
chr1_+_87522267 | 2.72 |
ENSMUST00000165109.2
ENSMUST00000070898.6 |
Neu2
|
neuraminidase 2 |
chr15_-_96929086 | 2.72 |
ENSMUST00000230086.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr2_-_155849839 | 2.71 |
ENSMUST00000086145.10
ENSMUST00000144686.8 ENSMUST00000140657.8 |
6430550D23Rik
|
RIKEN cDNA 6430550D23 gene |
chr13_-_56696310 | 2.70 |
ENSMUST00000062806.6
|
Lect2
|
leukocyte cell-derived chemotaxin 2 |
chr2_-_91540864 | 2.68 |
ENSMUST00000028678.9
ENSMUST00000076803.12 |
Atg13
|
autophagy related 13 |
chr14_+_119175328 | 2.68 |
ENSMUST00000022734.9
|
Dnajc3
|
DnaJ heat shock protein family (Hsp40) member C3 |
chr2_+_133394079 | 2.67 |
ENSMUST00000028836.7
|
Bmp2
|
bone morphogenetic protein 2 |
chr1_-_162726053 | 2.63 |
ENSMUST00000143123.3
|
Fmo2
|
flavin containing monooxygenase 2 |
chr10_-_128245501 | 2.63 |
ENSMUST00000172348.8
ENSMUST00000166608.8 ENSMUST00000164199.8 ENSMUST00000171370.2 ENSMUST00000026439.14 |
Nabp2
|
nucleic acid binding protein 2 |
chr15_+_99291100 | 2.62 |
ENSMUST00000159209.8
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr18_+_56565188 | 2.61 |
ENSMUST00000070166.6
|
Gramd3
|
GRAM domain containing 3 |
chr12_-_44256843 | 2.59 |
ENSMUST00000220421.2
|
Dnajb9
|
DnaJ heat shock protein family (Hsp40) member B9 |
chr2_-_5680801 | 2.58 |
ENSMUST00000114987.4
|
Camk1d
|
calcium/calmodulin-dependent protein kinase ID |
chr10_-_31485180 | 2.56 |
ENSMUST00000081989.8
|
Rnf217
|
ring finger protein 217 |
chrX_-_163763337 | 2.55 |
ENSMUST00000112248.9
|
Mospd2
|
motile sperm domain containing 2 |
chr7_+_119499322 | 2.54 |
ENSMUST00000106516.2
|
Lyrm1
|
LYR motif containing 1 |
chr2_+_33106062 | 2.54 |
ENSMUST00000004208.7
|
Angptl2
|
angiopoietin-like 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.8 | 23.5 | GO:1903699 | tarsal gland development(GO:1903699) |
7.6 | 22.7 | GO:1902617 | response to fluoride(GO:1902617) |
5.5 | 16.6 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
4.7 | 9.3 | GO:0002477 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
4.5 | 4.5 | GO:1900673 | olefin metabolic process(GO:1900673) |
3.3 | 9.8 | GO:1903920 | positive regulation of actin filament severing(GO:1903920) |
3.2 | 19.4 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
3.2 | 15.9 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
3.0 | 11.9 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
2.9 | 14.5 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
2.8 | 30.8 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
2.6 | 10.4 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
2.4 | 9.6 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
2.4 | 9.6 | GO:0006069 | ethanol oxidation(GO:0006069) |
2.2 | 13.3 | GO:0008355 | olfactory learning(GO:0008355) |
2.1 | 6.4 | GO:1904766 | negative regulation of macroautophagy by TORC1 signaling(GO:1904766) |
2.1 | 6.2 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
1.9 | 5.8 | GO:0046724 | oxalic acid secretion(GO:0046724) |
1.8 | 21.9 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
1.8 | 8.9 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
1.7 | 8.7 | GO:0009115 | xanthine catabolic process(GO:0009115) |
1.6 | 9.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
1.5 | 4.6 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.5 | 4.5 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.5 | 7.3 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
1.4 | 7.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
1.4 | 5.6 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
1.4 | 4.1 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.3 | 2.7 | GO:0003133 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
1.3 | 5.3 | GO:0006507 | GPI anchor release(GO:0006507) regulation of high-density lipoprotein particle clearance(GO:0010982) |
1.3 | 9.0 | GO:0060335 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) heme transport(GO:0015886) positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
1.3 | 13.8 | GO:0000255 | allantoin metabolic process(GO:0000255) |
1.2 | 3.5 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
1.1 | 20.6 | GO:0042448 | progesterone metabolic process(GO:0042448) |
1.1 | 3.4 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
1.1 | 4.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.1 | 3.4 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
1.1 | 27.5 | GO:0017144 | drug metabolic process(GO:0017144) |
1.1 | 7.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.0 | 4.2 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.0 | 6.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.0 | 10.3 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.0 | 3.0 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
1.0 | 2.9 | GO:0006583 | melanin biosynthetic process from tyrosine(GO:0006583) |
0.9 | 9.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.9 | 6.1 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.9 | 4.3 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.9 | 3.5 | GO:0015744 | succinate transport(GO:0015744) |
0.8 | 11.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.8 | 1.7 | GO:0046226 | coumarin metabolic process(GO:0009804) coumarin catabolic process(GO:0046226) |
0.8 | 2.4 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.7 | 2.2 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.7 | 3.7 | GO:0006116 | NADH oxidation(GO:0006116) |
0.7 | 2.2 | GO:1905072 | detection of oxygen(GO:0003032) cardiac jelly development(GO:1905072) |
0.7 | 3.6 | GO:0006548 | histidine catabolic process(GO:0006548) |
0.7 | 2.1 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.7 | 2.1 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.7 | 2.1 | GO:0061290 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.7 | 2.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.7 | 1.4 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
0.7 | 4.0 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.7 | 9.8 | GO:0032782 | bile acid secretion(GO:0032782) |
0.7 | 7.9 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.6 | 1.9 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.6 | 3.2 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.6 | 23.5 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.6 | 8.9 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.6 | 1.3 | GO:0097017 | renal protein absorption(GO:0097017) |
0.6 | 1.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.6 | 1.2 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.6 | 3.0 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.6 | 1.8 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.6 | 3.0 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.6 | 1.7 | GO:0071874 | smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) cellular response to norepinephrine stimulus(GO:0071874) |
0.6 | 5.7 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.5 | 2.7 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.5 | 1.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.5 | 5.7 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.5 | 2.1 | GO:0090472 | dibasic protein processing(GO:0090472) |
0.5 | 3.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.5 | 4.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.5 | 1.5 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.5 | 15.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.5 | 2.5 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.5 | 5.3 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.5 | 3.9 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.5 | 1.4 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.5 | 2.4 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.5 | 0.9 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.5 | 0.5 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.5 | 3.8 | GO:0051775 | response to redox state(GO:0051775) |
0.5 | 1.4 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
0.5 | 5.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.5 | 4.6 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.5 | 1.8 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.5 | 4.2 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.5 | 18.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.5 | 1.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.5 | 1.4 | GO:0021660 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.5 | 2.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.4 | 3.1 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.4 | 1.3 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.4 | 2.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.4 | 3.1 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.4 | 0.9 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.4 | 0.9 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.4 | 3.8 | GO:0019695 | choline metabolic process(GO:0019695) |
0.4 | 2.1 | GO:0046709 | purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
0.4 | 2.5 | GO:1900245 | negative regulation of MDA-5 signaling pathway(GO:0039534) positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.4 | 2.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.4 | 1.2 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.4 | 1.2 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
0.4 | 3.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.4 | 1.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.4 | 4.7 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.4 | 1.6 | GO:0050960 | detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
0.4 | 0.8 | GO:0021586 | pons maturation(GO:0021586) |
0.4 | 1.5 | GO:0021905 | pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) sensory neuron migration(GO:1904937) |
0.4 | 1.5 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.4 | 2.3 | GO:1990839 | response to endothelin(GO:1990839) |
0.4 | 1.1 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
0.4 | 1.1 | GO:0035603 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
0.4 | 1.5 | GO:0015755 | fructose transport(GO:0015755) |
0.4 | 0.7 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
0.4 | 1.1 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.4 | 0.7 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.4 | 2.8 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.3 | 3.8 | GO:0097421 | liver regeneration(GO:0097421) |
0.3 | 2.8 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.3 | 0.7 | GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
0.3 | 2.9 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.3 | 1.3 | GO:0045006 | DNA deamination(GO:0045006) |
0.3 | 1.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.3 | 1.2 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.3 | 3.3 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.3 | 0.9 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
0.3 | 2.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 1.2 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.3 | 2.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.3 | 1.1 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.3 | 0.8 | GO:0048691 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
0.3 | 1.7 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.3 | 5.6 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 1.1 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.3 | 2.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.3 | 1.3 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.3 | 2.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.3 | 1.3 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.3 | 1.6 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.3 | 0.8 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.3 | 1.0 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.3 | 3.9 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 2.3 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.3 | 5.1 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.3 | 2.3 | GO:0019627 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
0.3 | 1.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) calcium ion regulated lysosome exocytosis(GO:1990927) |
0.2 | 3.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 1.5 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.2 | 3.2 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.2 | 0.7 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.2 | 1.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.7 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 1.9 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 1.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 1.4 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 0.7 | GO:0002786 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
0.2 | 0.7 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.2 | 1.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.9 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.2 | 1.8 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.2 | 7.7 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.2 | 1.3 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.2 | 0.9 | GO:0000239 | pachytene(GO:0000239) |
0.2 | 5.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 1.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 1.3 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.2 | 1.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 0.6 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.2 | 0.6 | GO:0015881 | creatine transport(GO:0015881) |
0.2 | 1.9 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.2 | 3.3 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.2 | 11.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 0.8 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.2 | 2.2 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.2 | 0.6 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.2 | 3.6 | GO:0015695 | organic cation transport(GO:0015695) |
0.2 | 2.0 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.2 | 1.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 1.1 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.2 | 2.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 13.2 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.2 | 4.0 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 0.9 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.2 | 0.4 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
0.2 | 0.7 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.2 | 2.0 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.2 | 2.0 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 5.9 | GO:0032094 | response to food(GO:0032094) |
0.2 | 2.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 25.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 1.0 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.2 | 0.5 | GO:0040040 | thermosensory behavior(GO:0040040) |
0.2 | 2.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 2.6 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.2 | 0.9 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.2 | 1.5 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.2 | 2.9 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 1.0 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.2 | 1.0 | GO:0050917 | sensory perception of sweet taste(GO:0050916) sensory perception of umami taste(GO:0050917) |
0.2 | 1.0 | GO:0071484 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.2 | 0.5 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.2 | 1.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 0.5 | GO:0051385 | response to mineralocorticoid(GO:0051385) regulation of cardiac vascular smooth muscle cell differentiation(GO:2000722) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
0.2 | 1.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.2 | 1.0 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.2 | 3.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 3.5 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.2 | 11.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.2 | 3.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 1.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 1.8 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 4.7 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 2.8 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 4.4 | GO:0032108 | negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
0.1 | 0.6 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.3 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 3.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 1.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.9 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.7 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 1.7 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 2.8 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 3.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 2.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.4 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 1.8 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 2.7 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 0.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 16.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 1.0 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.7 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 3.6 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.4 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) positive regulation of hindgut contraction(GO:0060450) |
0.1 | 2.0 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 2.2 | GO:0050913 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) sensory perception of bitter taste(GO:0050913) |
0.1 | 2.7 | GO:0000423 | macromitophagy(GO:0000423) response to mitochondrial depolarisation(GO:0098780) |
0.1 | 1.9 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.5 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.8 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.4 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 3.6 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.4 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.1 | 0.6 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.5 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.1 | 2.1 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 1.4 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 1.6 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.2 | GO:1901738 | regulation of isoprenoid metabolic process(GO:0019747) regulation of vitamin A metabolic process(GO:1901738) |
0.1 | 0.4 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 5.3 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.6 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 | 0.5 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.5 | GO:0044805 | late nucleophagy(GO:0044805) |
0.1 | 2.4 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 3.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 1.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.8 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 1.8 | GO:0036296 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) |
0.1 | 1.0 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 2.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.2 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.1 | 2.6 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.1 | 1.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.6 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 1.1 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 1.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 0.5 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 1.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.5 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.1 | 0.4 | GO:0090282 | trophectodermal cellular morphogenesis(GO:0001831) positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
0.1 | 1.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 2.3 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 5.4 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.1 | 2.9 | GO:2000757 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.1 | 2.4 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.1 | 1.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 1.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 1.2 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 1.6 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.1 | 0.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 1.1 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 0.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.3 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.1 | 0.4 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.1 | 0.7 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 1.1 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.1 | 0.8 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
0.1 | 0.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.4 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.1 | 3.0 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.7 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 6.2 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.6 | GO:0042228 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) interleukin-8 biosynthetic process(GO:0042228) |
0.1 | 2.9 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 2.5 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.8 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.1 | 1.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.5 | GO:0001705 | ectoderm formation(GO:0001705) |
0.1 | 1.2 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) |
0.1 | 0.9 | GO:0015824 | proline transport(GO:0015824) |
0.1 | 0.9 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 1.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.2 | GO:0021558 | oculomotor nerve development(GO:0021557) trochlear nerve development(GO:0021558) |
0.1 | 0.7 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.7 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 2.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.5 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 0.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.5 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 1.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.7 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 0.6 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.3 | GO:0009305 | protein biotinylation(GO:0009305) response to biotin(GO:0070781) histone biotinylation(GO:0071110) |
0.1 | 0.6 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 1.0 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 1.0 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 4.7 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.1 | GO:1990705 | intrahepatic bile duct development(GO:0035622) cholangiocyte proliferation(GO:1990705) |
0.1 | 1.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.6 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 1.1 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.4 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 1.2 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 3.6 | GO:0060479 | lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
0.1 | 8.6 | GO:0030258 | lipid modification(GO:0030258) |
0.1 | 1.4 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 1.1 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 2.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.6 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.4 | GO:0072033 | renal vesicle formation(GO:0072033) ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.1 | 0.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.5 | GO:0042048 | olfactory behavior(GO:0042048) |
0.1 | 0.2 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.1 | 2.4 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 1.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.1 | GO:0031620 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.1 | 2.0 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.2 | GO:0061056 | sclerotome development(GO:0061056) |
0.1 | 1.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 2.1 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.3 | GO:0090032 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.0 | 1.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.1 | GO:0061196 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) regulation of anagen(GO:0051884) positive regulation of anagen(GO:0051885) fungiform papilla development(GO:0061196) |
0.0 | 0.2 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.0 | 0.8 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 0.7 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 0.1 | GO:0043060 | meiotic metaphase I plate congression(GO:0043060) meiotic metaphase plate congression(GO:0051311) |
0.0 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.0 | 0.2 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.0 | 0.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.9 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.3 | GO:1900040 | regulation of interleukin-2 secretion(GO:1900040) positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 | 0.9 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.1 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.0 | 0.1 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.0 | 0.8 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.4 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.5 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.0 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 2.0 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 1.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.6 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 1.6 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.2 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 1.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 1.2 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 | 0.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 1.7 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 2.3 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.0 | 1.2 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.0 | 1.3 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.4 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.0 | 0.8 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.0 | 0.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.9 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 1.3 | GO:0030858 | positive regulation of epithelial cell differentiation(GO:0030858) |
0.0 | 0.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.8 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.0 | 0.9 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.9 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.3 | GO:0031274 | regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.8 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.0 | 0.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 1.2 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 1.2 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 1.7 | GO:0048477 | oogenesis(GO:0048477) |
0.0 | 0.3 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.2 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.5 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 1.0 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 0.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.3 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.5 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.0 | 1.2 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.0 | 0.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.4 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.2 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.8 | GO:0009154 | purine ribonucleotide catabolic process(GO:0009154) ribonucleotide catabolic process(GO:0009261) |
0.0 | 0.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 4.3 | GO:0070085 | glycosylation(GO:0070085) |
0.0 | 0.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.0 | GO:1900225 | regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
0.0 | 0.3 | GO:2000780 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.0 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.0 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.3 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.0 | 0.2 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.0 | 0.1 | GO:0051231 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.0 | 0.1 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.9 | GO:0071774 | response to fibroblast growth factor(GO:0071774) |
0.0 | 0.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.3 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.2 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.2 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.4 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 8.7 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.4 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.2 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 0.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 14.7 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
2.7 | 40.0 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
2.2 | 31.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
2.1 | 6.4 | GO:0036020 | endolysosome membrane(GO:0036020) |
1.5 | 10.3 | GO:0097441 | basilar dendrite(GO:0097441) |
1.0 | 6.0 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.9 | 4.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.8 | 5.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.8 | 3.2 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.8 | 2.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.8 | 2.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.7 | 3.7 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.7 | 13.7 | GO:0045180 | basal cortex(GO:0045180) |
0.7 | 2.9 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.7 | 4.7 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.6 | 2.2 | GO:0070722 | Tle3-Aes complex(GO:0070722) |
0.5 | 2.7 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.5 | 7.4 | GO:0031983 | vesicle lumen(GO:0031983) |
0.5 | 6.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.5 | 3.4 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.5 | 3.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.5 | 7.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.4 | 2.6 | GO:0070876 | SOSS complex(GO:0070876) |
0.4 | 2.2 | GO:0017177 | glucosidase II complex(GO:0017177) |
0.4 | 1.3 | GO:0071546 | pi-body(GO:0071546) |
0.4 | 11.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 2.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.4 | 4.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.4 | 2.5 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.4 | 4.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.4 | 16.3 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.4 | 7.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 4.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 4.0 | GO:0097433 | dense body(GO:0097433) |
0.3 | 66.7 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.3 | 3.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 2.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.3 | 1.5 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 4.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.3 | 2.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 4.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.7 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 0.9 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 5.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 1.7 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 0.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 3.8 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 5.1 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 2.0 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.2 | 2.9 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 1.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.5 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 41.0 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 1.0 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 3.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 2.9 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 1.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 1.2 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.9 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 1.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.9 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 2.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 4.1 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 34.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 3.9 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 3.1 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.7 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.8 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 2.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.8 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.8 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 2.1 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.9 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 7.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 1.7 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.7 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 2.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.3 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 4.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.5 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 1.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 2.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.6 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 1.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.3 | GO:1990844 | subsarcolemmal mitochondrion(GO:1990843) interfibrillar mitochondrion(GO:1990844) |
0.1 | 0.9 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 2.9 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 1.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 1.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.8 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 2.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 1.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 105.0 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.6 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.6 | GO:0044754 | autolysosome(GO:0044754) |
0.1 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 1.0 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.9 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.1 | GO:0005715 | late recombination nodule(GO:0005715) |
0.0 | 0.2 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
0.0 | 1.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 1.0 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.1 | GO:0002095 | caveolar macromolecular signaling complex(GO:0002095) |
0.0 | 4.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 2.4 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 2.6 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.8 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.8 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.2 | GO:0016528 | sarcoplasm(GO:0016528) |
0.0 | 5.3 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.9 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 1.9 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 1.2 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.6 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.3 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 1.1 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 1.3 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.2 | GO:0001652 | granular component(GO:0001652) |
0.0 | 1.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 1.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.5 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.0 | GO:0097361 | CIA complex(GO:0097361) |
0.0 | 0.2 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 4.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.8 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 2.0 | GO:0000139 | Golgi membrane(GO:0000139) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 24.3 | GO:0004063 | aryldialkylphosphatase activity(GO:0004063) |
4.9 | 14.7 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
4.6 | 27.7 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
4.5 | 27.2 | GO:0008142 | oxysterol binding(GO:0008142) |
4.2 | 16.6 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
3.7 | 18.7 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
3.2 | 9.6 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
2.9 | 8.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
2.9 | 8.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
2.7 | 10.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
2.7 | 13.3 | GO:0005186 | pheromone activity(GO:0005186) |
2.6 | 10.4 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
2.5 | 7.4 | GO:0052870 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
2.4 | 7.3 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
2.3 | 9.0 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
2.1 | 23.5 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
2.1 | 10.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
1.9 | 13.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.7 | 8.7 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) molybdenum ion binding(GO:0030151) |
1.7 | 8.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
1.6 | 4.9 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
1.6 | 15.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.5 | 12.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
1.5 | 9.0 | GO:0015232 | heme transporter activity(GO:0015232) |
1.4 | 14.5 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
1.4 | 4.3 | GO:0034632 | retinol transporter activity(GO:0034632) |
1.4 | 5.6 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
1.4 | 2.7 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
1.3 | 21.9 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
1.3 | 3.8 | GO:0002061 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) |
1.3 | 27.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
1.3 | 5.0 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
1.2 | 32.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.2 | 6.2 | GO:0004925 | prolactin receptor activity(GO:0004925) |
1.2 | 7.3 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
1.2 | 39.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
1.2 | 4.7 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.2 | 3.5 | GO:0008775 | acetate CoA-transferase activity(GO:0008775) |
1.2 | 3.5 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
1.1 | 4.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.1 | 22.8 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
1.1 | 3.2 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) 3 iron, 4 sulfur cluster binding(GO:0051538) |
1.0 | 3.0 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.9 | 11.7 | GO:0016151 | nickel cation binding(GO:0016151) |
0.9 | 5.3 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.9 | 2.6 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.9 | 2.6 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.9 | 4.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.9 | 3.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.8 | 2.5 | GO:0052692 | raffinose alpha-galactosidase activity(GO:0052692) |
0.8 | 32.4 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.8 | 3.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.8 | 7.7 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.8 | 4.6 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.7 | 2.9 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.7 | 2.8 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.7 | 5.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.7 | 2.8 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.7 | 2.1 | GO:0045030 | UTP-activated nucleotide receptor activity(GO:0045030) |
0.7 | 2.1 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.7 | 4.0 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.7 | 3.9 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.6 | 3.6 | GO:0030294 | receptor signaling protein tyrosine kinase inhibitor activity(GO:0030294) |
0.6 | 5.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.6 | 2.8 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.6 | 4.5 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.5 | 2.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.5 | 4.9 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.5 | 2.7 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.5 | 7.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.5 | 1.5 | GO:0015292 | fructose transmembrane transporter activity(GO:0005353) uniporter activity(GO:0015292) |
0.5 | 2.9 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.5 | 1.9 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.5 | 1.4 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.5 | 1.9 | GO:0004096 | catalase activity(GO:0004096) |
0.5 | 3.2 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.5 | 2.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 3.1 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.4 | 11.9 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.4 | 2.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.4 | 3.0 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.4 | 1.2 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.4 | 1.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.4 | 1.2 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.4 | 1.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.4 | 1.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.4 | 5.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 3.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.4 | 2.6 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.4 | 1.8 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.4 | 1.4 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.4 | 3.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.4 | 4.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 2.8 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 2.1 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.3 | 1.0 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.3 | 1.0 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.3 | 1.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.3 | 5.4 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.3 | 4.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.3 | 1.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.3 | 3.6 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.3 | 0.9 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
0.3 | 0.9 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.3 | 7.4 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.3 | 7.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 2.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.3 | 3.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 1.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 1.3 | GO:2001069 | glycogen binding(GO:2001069) |
0.3 | 1.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 5.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 1.7 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 0.9 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.2 | 1.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 2.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 1.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 2.3 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 4.3 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 0.9 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.2 | 1.6 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.2 | 3.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 1.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 0.9 | GO:0019809 | spermidine binding(GO:0019809) |
0.2 | 0.6 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.2 | 19.4 | GO:0020037 | heme binding(GO:0020037) |
0.2 | 2.0 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.2 | 6.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.2 | 4.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 2.9 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 2.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 2.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 2.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.2 | 0.7 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.2 | 1.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 0.7 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 1.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 1.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.2 | 1.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.2 | 1.0 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 2.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 3.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 2.0 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.2 | 0.5 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.2 | 2.9 | GO:0015250 | water channel activity(GO:0015250) |
0.2 | 0.9 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.2 | 1.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 0.8 | GO:0070287 | ferritin receptor activity(GO:0070287) |
0.2 | 3.4 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.2 | 1.4 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 4.1 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 1.9 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.6 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 1.8 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 5.0 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 0.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 1.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 1.0 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.4 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
0.1 | 3.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 3.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 26.2 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.1 | 1.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 2.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 1.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 2.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 1.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 1.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 1.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.6 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 3.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 4.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.5 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.1 | 1.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.7 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.9 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 1.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 2.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 1.1 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 1.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 1.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 1.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 4.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 1.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 1.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 1.8 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.7 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 1.3 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 1.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 5.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 1.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 3.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.8 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 1.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.6 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 12.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 4.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.7 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.1 | 0.9 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 2.6 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 6.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.5 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.1 | 0.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 3.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 2.2 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 8.3 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.3 | GO:0004080 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
0.1 | 7.5 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 2.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 1.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 1.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 12.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 2.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 3.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 4.0 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 2.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.6 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 2.9 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 1.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.4 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 1.4 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.8 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 1.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.7 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.1 | 0.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 1.7 | GO:0008236 | serine-type peptidase activity(GO:0008236) serine hydrolase activity(GO:0017171) |
0.1 | 1.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.3 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 1.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 1.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 3.8 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 1.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 2.2 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 2.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 1.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 1.4 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.0 | 3.9 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 1.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 1.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.8 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 0.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 1.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.4 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 1.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.5 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 3.5 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 1.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.5 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.4 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 1.5 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 2.3 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 1.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.2 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 0.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 1.1 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.1 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.0 | 0.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.3 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 0.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.1 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.0 | 0.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 1.5 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.3 | GO:0004629 | phosphatidylinositol phospholipase C activity(GO:0004435) phospholipase C activity(GO:0004629) |
0.0 | 9.5 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.0 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.3 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.1 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.0 | 2.7 | GO:0051015 | actin filament binding(GO:0051015) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 2.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.6 | 48.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 4.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 6.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 7.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 4.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 4.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 5.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 9.7 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 3.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 2.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 10.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 5.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 3.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 1.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 1.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 4.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 2.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 8.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 3.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 5.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 3.9 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 5.4 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 4.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 3.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 4.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 2.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 2.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 1.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 1.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 1.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 1.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 1.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 1.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 2.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 2.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 1.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 3.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 4.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.5 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.4 | 34.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
3.0 | 8.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.6 | 17.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
1.5 | 21.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.4 | 21.0 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
1.1 | 13.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.8 | 12.2 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.8 | 22.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.5 | 8.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 17.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.5 | 10.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.5 | 7.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.4 | 4.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 24.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.4 | 4.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 36.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.4 | 2.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.3 | 12.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 6.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 5.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 5.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 3.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 4.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 13.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 2.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.3 | 5.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 6.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 5.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 7.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 2.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 6.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 2.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 2.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 1.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 4.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 3.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 3.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 4.5 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.2 | 1.7 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.2 | 5.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 10.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 2.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 2.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 2.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 6.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 2.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 7.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 3.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 1.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 3.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 2.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 4.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 5.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 3.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 2.1 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 2.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 2.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 1.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 4.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 1.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 1.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 1.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 3.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 3.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 8.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 2.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 1.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.6 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 1.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 1.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 1.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 2.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.6 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 1.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 1.3 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.2 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 1.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.6 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.2 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 0.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.4 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.7 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.5 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |